Chestnut Hill, MA, United States of America

Matthew Duncton


 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Wayne, PA (US) (2021)
  • Chestnut Hill, MA (US) (2021 - 2023)
  • Boston, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Duncton

Introduction

Matthew Duncton is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dermal disorders. With a total of seven patents to his name, Duncton has established himself as a key figure in innovation.

Latest Patents

Duncton's latest patents include groundbreaking compounds designed for the treatment of dermal disorders. One of his notable inventions is the Pyrrolopyridine-aniline compound, which provides pharmaceutical compositions and methods for treating diseases where an inhibitor of MEK is required. Another significant patent is the Naphthyridinone-aniline compound, which also focuses on treating dermal disorders through similar methods and compositions.

Career Highlights

Matthew Duncton is currently associated with Nflection Therapeutics, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing treatments that address complex medical conditions.

Collaborations

Duncton collaborates with various professionals in his field, including his coworker John Kincaid. Together, they work towards enhancing the efficacy of treatments and expanding the scope of their research.

Conclusion

Matthew Duncton's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of dermal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…